デフォルト表紙
市場調査レポート
商品コード
1464654

バイオプロセスバリデーション市場：試験タイプ別、プロセスコンポーネント別、エンドユーザー別、国別、地域別-2024-2032年の産業分析、市場規模、市場シェア、予測

Bioprocess validation Market, By Test Type, By Process Component, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 260 Pages
納期
2～3営業日
カスタマイズ可能
バイオプロセスバリデーション市場：試験タイプ別、プロセスコンポーネント別、エンドユーザー別、国別、地域別-2024-2032年の産業分析、市場規模、市場シェア、予測
出版日: 2024年04月01日
発行: AnalystView Market Insights
ページ情報: 英文 260 Pages
納期: 2～3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 図表
  • 目次
概要

レポートハイライト

バイオプロセスバリデーション市場規模は2023年に4億2,091万米ドルとなり、2024年から2032年にかけてCAGR 9.83％で拡大

バイオプロセスバリデーション市場-市場力学

バイオプロセスバリデーションのアウトソーシング需要の急増とライフサイエンス研究開発費の増加が市場成長の原動力になると予測されます。

数多くの製薬企業やバイオテクノロジー企業が、バイオプロセスバリデーションなど業務のさまざまな側面を委託するケースが増えています。ライフサイエンス分野の研究開発活動の拡大に伴い、新しいバイオ医薬品の開発と生産を促進するためのバイオプロセスバリデーションに関連するサービスへの需要が高まっています。世界の研究開発費は約1兆7,000億米ドルに急増し、その80％を約10カ国が占めています。ユネスコ統計研究所（UIS）によれば、持続可能な開発目標（SDGs）の一環として、各国は2030年までに研究者数だけでなく、公的・私的研究開発支出を大幅に増加させることを約束しています。さらに、バイオプロセス技術と規制遵守要件の進歩は、市場に成長機会をもたらす可能性があります。しかし、バリデーションにかかるコストの高さが市場の成長を阻害する可能性もあります。

バイオプロセスバリデーション市場-主要インサイト

リサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約9.83%のCAGRで毎年成長すると推定されます。

試験タイプ別では、抽出物および浸出物試験が2023年に最大市場シェアを示すと予測されています。

プロセスコンポーネント別では、2023年にはフィルターエレメントが主要タイプでした。

エンドユーザー別では、製薬・バイオテクノロジー企業が2023年の主要タイプでした。

地域別では、北米が2023年の主要収益源であった。

バイオプロセスバリデーション市場-セグメンテーション分析：

世界のバイオプロセスバリデーション市場は、試験タイプ、プロセスコンポーネント、エンドユーザー、地域に基づいてセグメント化されます。

市場は試験タイプによって4つのグループに分類される：抽出物・溶出物試験、バイオプロセス残留物試験、ウイルスクリアランス試験、ろ過・発酵システム試験、その他です。市場の主流は、抽出物・浸出物試験です。この製品タイプは、医薬品の開発・製造、特にバイオ医薬品製造に使用される包装材料、容器、処理装置に関して重要な役割を果たしています。

市場はプロセスコンポーネントによって5つのカテゴリーに区分される：フィルターエレメント、メディア容器・バッグ、凍結・解凍プロセスバッグ、ミキシングシステム、バイオリアクター、トランスファーシステム、その他です。フィルターエレメントは市場をリードするカテゴリーです。バイオ医薬品製造プロセス、特に下流工程で重要な役割を果たしています。

市場はエンドユーザーによって3つのグループに区分される：製薬・バイオテクノロジー企業、開発・製造受託機関、その他です。市場を独占しているのは製薬・バイオテクノロジー企業です。これらの企業は、バイオプロセスバリデーションサービスの需要を牽引する重要な役割を果たしています。バイオ医薬品の開発・製造に携わる企業にとって、製造プロセスにおいて一貫した品質を維持し、規制基準を遵守することは極めて重要です。

バイオプロセスバリデーション市場-地理的洞察

バイオプロセスバリデーション市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカにまたがっています。これらの地域は、事業活動に貢献している国によってさらに区分されます。市場は主に北米、特に米国が牽引すると予想されるが、これはバイオ医薬品の需要が高まっているためです。米国は強力で確立されたバイオ医薬品産業を誇っています。バイオプロセスのバリデーションは、バイオ医薬品の品質、安全性、有効性を確保する上で重要な役割を果たすため、バリデーションサービスや製品に対する需要が高まっています。医薬品統計によると、米国の医薬品業界は2021年に5,500億米ドルの収益を記録し、米国人は5,769億米ドルを医薬品に費やしました。欧州は市場成長率第2位の地域です。

バイオプロセスバリデーション市場-競合情勢：

バイオ医薬品に対するニーズの高まり、バイオプロセス技術の進歩、厳格な規制基準の結果、バイオプロセスバリデーション市場は大幅な成長を遂げています。この市場のメーカーは常に革新に努め、バイオプロセスをバリデートするための最先端の技術や手法を生み出しています。技術革新の最前線に立ち続けることで、これらの企業は、より効率的で正確かつコスト効率の高いバリデーションソリューションを提供し、競争上の優位性を獲得しています。さらに、顧客満足度を優先し、消費者と強い関係を築いている企業は、リピートビジネスや譲渡によって利益を得ることが多く、競争力をさらに高めています。

目次

第1章 バイオプロセスバリデーション市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 バイオプロセスバリデーションの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 バイオプロセスバリデーション産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 バイオプロセスバリデーション市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 バイオプロセスバリデーション市場情勢

  • バイオプロセスバリデーション市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 バイオプロセス検証市場- 試験タイプ別

  • 概要
    • 試験タイプ別セグメントシェア分析
    • 抽出物および浸出物試験
    • バイオプロセス残留物試験
    • ウイルスクリアランステスト
    • 濾過・発酵システムの試験
    • その他

第8章 バイオプロセスバリデーション市場- プロセスコンポーネント別

  • 概要
    • プロセスコンポーネント別セグメントシェア分析
    • フィルターエレメント
    • メディア容器とバッグ
    • 凍結・解凍処理バッグ
    • ミキシングシステム
    • バイオリアクター
    • トランスファーシステム
    • その他

第9章 バイオプロセスバリデーション市場- エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 製薬・バイオテクノロジー企業
    • 契約開発および製造組織
    • その他

第10章 バイオプロセスバリデーション市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- バイオプロセスバリデーション業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Eurofins Scientific, Inc.
    • Sartorius AG
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • Lonza
    • Danaher Corporation
    • Charles River Laboratories
    • SGS SA
    • Toxikon Corporation
    • Cobetter Filtration Equipment Co., Ltd.
    • Others

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Bioprocess Validation Market: Test Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Test Type
  • TABLE Global Bioprocess Validation Market, by Test Type 2019-2032 (USD Million)
  • TABLE Bioprocess Validation Market: Process Component Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Process Component
  • TABLE Global Bioprocess Validation Market, by Process Component 2019-2032 (USD Million)
  • TABLE Bioprocess Validation Market: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Bioprocess Validation Market, by End-User 2019-2032 (USD Million)
  • TABLE Bioprocess Validation Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Bioprocess Validation Market, by Region 2019-2032 (USD Million)
  • TABLE North America Bioprocess Validation Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Bioprocess Validation Market, by Test Type, 2019-2032 (USD Million)
  • TABLE North America Bioprocess Validation Market, by Process Component, 2019-2032 (USD Million)
  • TABLE North America Bioprocess Validation Market, by End-User, 2019-2032 (USD Million)
  • TABLE Europe Bioprocess Validation Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Bioprocess Validation Market, by Test Type, 2019-2032 (USD Million)
  • TABLE Europe Bioprocess Validation Market, by Process Component, 2019-2032 (USD Million)
  • TABLE Europe Bioprocess Validation Market, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Bioprocess Validation Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Bioprocess Validation Market, by Test Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Bioprocess Validation Market, by Process Component, 2019-2032 (USD Million)
  • TABLE Asia Pacific Bioprocess Validation Market, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America Bioprocess Validation Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Bioprocess Validation Market, by Test Type, 2019-2032 (USD Million)
  • TABLE Latin America Bioprocess Validation Market, by Process Component, 2019-2032 (USD Million)
  • TABLE Latin America Bioprocess Validation Market, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Bioprocess Validation Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Bioprocess Validation Market, by Test Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Bioprocess Validation Market, by Process Component, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Bioprocess Validation Market, by End-User, 2019-2032 (USD Million)
目次
Product Code: ANV2456

REPORT HIGHLIGHT

Bioprocess validation Market size was valued at USD 420.91 Million in 2023, expanding at a CAGR of 9.83% from 2024 to 2032.

Bioprocess validation plays a vital role in guaranteeing the safety, quality, and effectiveness of bioproducts, including vaccines, antibodies, enzymes, and biosensors. Its purpose is to demonstrate that a bioprocess can consistently generate the desired bioproduct according to predetermined specifications and conditions. In the pharmaceutical industry, bioprocess validation is a mandatory regulatory requirement that ensures the uniformity and excellence of biopharmaceutical products throughout their entire lifespan.

Bioprocess validation Market- Market Dynamics

Surge in demand for outsourcing bioprocess validation and increase in life science R&D expenditure are expected to drive the market growth.

Numerous pharmaceutical and biotechnology companies are increasingly delegating various aspects of their operations, such as bioprocess validation. With the expansion of R&D activities in the life sciences sector, there is a rising demand for services related to bioprocess validation to facilitate the development and production of new biopharmaceutical products. Global expenditure on R&D has surged to nearly US$ 1.7 trillion, with approximately 10 countries contributing to 80% of the spending. As part of the Sustainable Development Goals (SDGs), nations have committed to significantly boosting public and private R&D expenditure, as well as the number of researchers, by 2030, as per the UNESCO Institute for Statistics (UIS). Additionally, advancements in bioprocessing technologies and regulatory compliance requirements may present growth opportunities for the market. Nonetheless, the high cost of validation could impede market growth.

Bioprocess validation Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.83% over the forecast period (2024-2032)

Based on Test Type segmentation, Extractables & Leachables Testing was predicted to show maximum market share in the year 2023

Based on Process Component segmentation, Filter Elements was the leading type in 2023

Based on End-User segmentation, Pharmaceutical & Biotechnology Companies was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Bioprocess validation Market- Segmentation Analysis:

The Global Bioprocess validation Market is segmented on the basis of Test Type, Process Component, End-User, and Region.

The market is categorized into four groups according to the Test Type: Extractables & Leachables Testing, Bioprocess Residuals Testing, Viral Clearance Testing, Filtration & Fermentation Systems Testing, and Others. The dominant category in the market is Extractables & Leachables Testing. This type of testing plays a crucial role in the development and manufacturing of pharmaceutical products, especially when it comes to packaging materials, containers, and processing equipment used in biopharmaceutical production.

The market is segmented into five categories according to Process Component: Filter Elements, Media containers and bags, Freezing And Thawing Process Bags, Mixing Systems, Bioreactors, Transfer Systems and Others. Filter Elements are the leading category in the market. They play a vital role in biopharmaceutical manufacturing processes, especially in downstream processing.

The market is segmented into three groups according to the end-users: Pharmaceutical & Biotechnology Companies, Contract Development & Manufacturing Organizations, and Other. The dominant force in the market is the Pharmaceutical & Biotechnology Companies. These companies play a significant role in driving the demand for bioprocess validation services. Given their involvement in the development and production of biopharmaceutical products, it is crucial for them to maintain consistent quality and adhere to regulatory standards in their manufacturing processes.

Bioprocess validation Market- Geographical Insights

Geographically, this market spans across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further segmented by countries contributing to business activities. The market is anticipated to be primarily driven by North America, particularly the United States, owing to the rising demand for Biopharmaceuticals. The United States boasts a strong and well-established biopharmaceutical industry. Validation of bioprocesses plays a critical role in ensuring the quality, safety, and effectiveness of biopharmaceutical products, leading to an increased demand for validation services and products. As per Pharmaceutical Statistics, the U.S. pharmaceutical industry recorded a revenue of $550 billion in 2021, while Americans spent USD 576.9 billion on medications. Europe stands as the second-largest region for market growth.

Bioprocess validation Market- Competitive Landscape:

The bioprocess validation market is experiencing substantial growth as a result of the rising need for biopharmaceuticals, advancements in bioprocess technology, and strict regulatory standards. Manufactures in this market are constantly striving to innovate and create cutting-edge technologies and methodologies for validating bioprocesses. By staying at the forefront of innovation, these companies gain a competitive advantage by providing validation solutions that are more efficient, accurate, and cost-effective. Additionally, companies that prioritize customer satisfaction and establish strong consumer relationships often benefit from repeat business and transfers, further enhancing their competitive position.

Recent Developments:

Eurofins BioPharma Product Testing Columbia part of the biggest network of harmonized bio/pharmaceutical GMP product testing facilities globally, announced a collaboration agreement with Plus Therapeutics, Inc. ("Plus Therapeutics"), a clinical stage pharmaceutical company developing novel, targeted therapies for rare and difficult cancers.

April 30, 2020, Merck, a leading science and technology company, today unveiled the next component of its BioContinuum Platform, the Bio4C Software Suite, generating a first-of-its-kind ecosystem that syndicates process control, analytics as well as plant-level automation.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOPROCESS VALIDATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Eurofins Scientific, Inc.

Sartorius AG

Merck KGaA

Thermo Fisher Scientific Inc.

Lonza

Danaher Corporation

Charles River Laboratories

SGS S.A.

Toxikon Corporation

Cobetter Filtration Equipment Co., Ltd.

Others

GLOBAL BIOPROCESS VALIDATION MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Extractables & Leachables Testing
  • Bioprocess Residuals Testing
  • Viral Clearance Testing
  • Filtration & Fermentation Systems Testing
  • Others

GLOBAL BIOPROCESS VALIDATION MARKET, BY PROCESS COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Filter Elements
  • Media containers and bags
  • Freezing And Thawing Process Bags
  • Mixing Systems
  • Bioreactors
  • Transfer Systems
  • Others

GLOBAL BIOPROCESS VALIDATION MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical & Biotechnology Companies
  • Contract Development & Manufacturing Organizations
  • Other

GLOBAL BIOPROCESS VALIDATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Bioprocess Validation Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Bioprocess Validation Market Snippet by Test Type
    • 2.1.2.Bioprocess Validation Market Snippet by Process Component
    • 2.1.3.Bioprocess Validation Market Snippet by End-User
    • 2.1.4.Bioprocess Validation Market Snippet by Country
    • 2.1.5.Bioprocess Validation Market Snippet by Region
  • 2.2.Competitive Insights

3.Bioprocess Validation Key Market Trends

  • 3.1.Bioprocess Validation Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Bioprocess Validation Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Bioprocess Validation Market Opportunities
  • 3.4.Bioprocess Validation Market Future Trends

4.Bioprocess Validation Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Bioprocess Validation Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Bioprocess Validation Market Landscape

  • 6.1.Bioprocess Validation Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Bioprocess Validation Market - By Test Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Test Type, 2023 & 2032 (%)
    • 7.1.2.Extractables & Leachables Testing
    • 7.1.3.Bioprocess Residuals Testing
    • 7.1.4.Viral Clearance Testing
    • 7.1.5.Filtration & Fermentation Systems Testing
    • 7.1.6.Others

8.Bioprocess Validation Market - By Process Component

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Process Component, 2023 & 2032 (%)
    • 8.1.2.Filter Elements
    • 8.1.3.Media containers and bags
    • 8.1.4.Freezing And Thawing Process Bags
    • 8.1.5.Mixing Systems
    • 8.1.6.Bioreactors
    • 8.1.7.Transfer Systems
    • 8.1.8.Others

9.Bioprocess Validation Market - By End-User

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2.Pharmaceutical & Biotechnology Companies
    • 9.1.3.Contract Development & Manufacturing Organizations
    • 9.1.4.Other

10.Bioprocess Validation Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Bioprocess Validation Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Bioprocess Validation Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Bioprocess Validation Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Bioprocess Validation Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Bioprocess Validation Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Process Component, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Bioprocess Validation Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.Eurofins Scientific, Inc.
    • 11.2.2.Sartorius AG
    • 11.2.3.Merck KGaA
    • 11.2.4.Thermo Fisher Scientific Inc.
    • 11.2.5.Lonza
    • 11.2.6.Danaher Corporation
    • 11.2.7.Charles River Laboratories
    • 11.2.8.SGS S.A.
    • 11.2.9.Toxikon Corporation
    • 11.2.10.Cobetter Filtration Equipment Co., Ltd.
    • 11.2.11.Others

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us